Dymon Asia Capital (Singapore) Pte. Ltd. Albemarle Corp Put Options Transaction History

Dymon Asia Capital (Singapore) Pte. Ltd.

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 12, 2024	BUY	$72.85 - $100.09 $509,949 - $700,630	7,000 New	7,000 $662,000
Q4 2022 Feb 13, 2023	BUY	$214.02 - $325.38 $7.49 Million - $11.4 Million	35,000 New	35,000 $7.59 Million
Q2 2022 Aug 12, 2022	SELL	$187.76 - $270.92 $938,800 - $1.35 Million	-5,000 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$172.09 - $246.0 $4.25 Million - $6.08 Million	-24,700 Reduced 83.16%	5,000 $1.11 Million
Q3 2021 Nov 12, 2021	BUY	$167.91 - $244.03 $4.99 Million - $7.25 Million	29,700 New	29,700 $6.5 Million
Q1 2021 May 14, 2021	SELL	$140.69 - $185.25 $3.7 Million - $4.87 Million	-26,300 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$86.73 - $149.91 $2.28 Million - $3.94 Million	26,300 New	26,300 $3.88 Million

928

104M

8.36M

14.3M

Ticker ALB
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 117,129,000
Market Cap $12.7B
Description
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and li...

Get notified when there are updates to the investment portfolio of Dymon Asia Capital (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

Stay updated on Dymon Asia Capital (Singapore) Pte. Ltd. with notifications on news.